• This record comes from PubMed

Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review

. 2022 Jan 17 ; 23 (1) : 28.

Language English Country Singapore Media print

Document type Systematic Review, Journal Article

Links

PubMed 35092220
DOI 10.31083/j.rcm2301028
PII: S1530-6550(22)00315-5
Knihovny.cz E-resources

BACKGROUND: Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China, the novel coronavirus disease 2019 (COVID-19) has caused more than five milion deaths worldwide. Several studies have elucidated the role of risk factors in the prognosis of cardiovascular disease (CVD) in the progression of COVID-19 pandemic. This systematic review assesses the link between COVID-19 and cardiovascular risk factors, and investigates the prognosis in the case of myocardial injury. METHODS: A literature search was performed to identify relevant articles in Pubmed, MEDLINE, Elsevier, and Google Scholar the last two years using the terms: COVID-19, CVD, risk factors, cardiovascular risk factors, SARS-CoV-2, lockdown, hypertension, and diabetes mellitus. Exclusion criteria were the studies associated with pediatric and pregnant COVID-19 patients. RESULTS: After screening through 3071 articles, 10 studies were included in this review that captured the findings from 3912 participants. Included studies found that preexisting CVD was linked to worse outcomes and increased risk of death in patients with COVID-19, whereas COVID-19 itself also induced myocardial injury, arrhythmia, acute coronary syndrome, and venous thromboembolism. CONCLUSIONS: Cardiovascular risk factors such as hypertension, diabetes mellitus, and obesity were associated with intensive care unit admission and poor prognosis. Cardiovascular risk factors are crucial for the progression of COVID-19, and infected patients should be constantly monitored and follow strict hygiene and decrease their social interactions.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

What can multiple causes of death tell about cardiovascular mortality during COVID-19 pandemic in the United States?

. 2024 Feb 23 ; 46 (1) : 97-106.

Efficacy of supervised home-based, real time, videoconferencing telerehabilitation in patients with type 2 diabetes: a single-blind randomized controlled trial

. 2023 Oct ; 59 (5) : 628-639. [epub] 20230623

The cost-effectiveness of exercise-based cardiac telerehabilitation intervention: a systematic review

. 2023 Apr ; 59 (2) : 248-258. [epub] 20230124

Tele-Assessment of Functional Capacity through the Six-Minute Walk Test in Patients with Diabetes Mellitus Type 2: Validity and Reliability of Repeated Measurements

. 2023 Jan 25 ; 23 (3) : . [epub] 20230125

How the COVID-19 pandemic influences the prevalence of pressure injuries in the Czech Republic: A nationwide analysis of a health registry in 2020

. 2022 Aug ; 31 (3) : 424-430. [epub] 20220615

Effectiveness of Home-Based Cardiac Rehabilitation, Using Wearable Sensors, as a Multicomponent, Cutting-Edge Intervention: A Systematic Review and Meta-Analysis

. 2022 Jun 29 ; 11 (13) : . [epub] 20220629

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...